Nifty
:
24056.00
Sensex
:
77100.47
34.35 (0.14%)
109.25 (0.14%)
Nifty
Sensex
:
:
24056.00
77100.47
34.35 (0.14%)
109.25 (0.14%)

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
67/99

BSE: 530549 | NSE: SHILPAMED

NSE BSE
571.60
25-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  584
  •  584
  •  569.7
  •  579.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  459304
  •  263452310.4
  •  598.9
  •  259.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11,178.48
  • 45.94
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,791.27
  • 0.11%
  • 4.31

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.13%
  • 8.83%
  • 27.71%
  • FII
  • DII
  • Others
  • 11.08%
  • 7.18%
  • 5.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.03
  • 7.38
  • 7.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.63
  • 12.10
  • 28.05

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.20
  • -11.93
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.57
  • 72.40
  • 61.94

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.49
  • 2.46
  • 2.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.23
  • 24.08
  • 24.27

Earnings Forecasts:

(Updated: 27-06-2026)
Description
2026
2027
2028
2029
Adj EPS
-
-
13.75
18.55
P/E Ratio
-
-
41.57
30.81
Revenue
-
1536.2
1786.05
2083.05
EBITDA
-
444.2
549.4
670.25
Net Income
-
218
269.15
363.65
ROA
-
-
-
-
P/B Ratio
-
4.32
3.88
3.46
ROE
-
8
9.6
11.7
FCFF
-
-
30.02
117.65
FCFF Yield
-
-
0.26
1.04
Net Debt
-
-
-
-
BVPS
-
132.2
147.3
165.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
436.99
330.82
32.09%
409.73
319.30
28.32%
369.97
343.80
7.61%
321.46
292.51
9.90%
Expenses
317.28
251.62
26.09%
295.43
238.66
23.79%
261.69
257.79
1.51%
229.82
218.99
4.95%
EBITDA
119.71
79.20
51.15%
114.30
80.65
41.72%
108.28
86.00
25.91%
91.64
73.52
24.65%
EBIDTM
27.39%
23.94%
27.90%
25.26%
29.27%
25.02%
28.51%
25.13%
Other Income
1.67
7.63
-78.11%
0.81
1.18
-31.36%
1.75
4.99
-64.93%
6.38
9.52
-32.98%
Interest
13.66
14.49
-5.73%
10.68
11.75
-9.11%
15.67
25.55
-38.67%
18.78
23.74
-20.89%
Depreciation
30.62
28.79
6.36%
30.36
28.81
5.38%
29.82
28.28
5.45%
28.92
27.11
6.68%
PBT
102.12
12.97
687.36%
61.21
41.27
48.32%
64.54
37.16
73.68%
50.31
32.20
56.24%
Tax
12.65
0.76
1,564.47%
16.27
9.83
65.51%
20.36
18.83
8.13%
2.69
14.62
-81.60%
PAT
89.47
12.21
632.76%
44.94
31.44
42.94%
44.18
18.33
141.03%
47.62
17.58
170.88%
PATM
20.47%
3.69%
10.97%
9.85%
11.94%
5.33%
14.81%
6.01%
EPS
5.51
0.74
644.59%
2.28
1.63
39.88%
2.25
0.92
144.57%
2.40
0.72
233.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
1,538.15
1,286.41
1,151.60
1,050.11
1,145.52
901.13
907.91
733.39
788.83
779.16
716.43
Net Sales Growth
19.57%
11.71%
9.66%
-8.33%
27.12%
-0.75%
23.80%
-7.03%
1.24%
8.76%
 
Cost Of Goods Sold
460.42
397.67
394.23
416.04
383.22
270.73
277.73
257.03
355.87
371.81
366.19
Gross Profit
1,077.73
888.74
757.37
634.07
762.30
630.40
630.18
476.36
432.95
407.36
350.25
GP Margin
70.07%
69.09%
65.77%
60.38%
66.55%
69.96%
69.41%
64.95%
54.89%
52.28%
48.89%
Total Expenditure
1,104.22
982.48
916.10
961.84
948.32
729.43
693.40
579.39
637.60
617.55
556.44
Power & Fuel Cost
-
53.74
52.41
56.79
52.43
40.25
38.76
33.57
28.86
26.30
21.90
% Of Sales
-
4.18%
4.55%
5.41%
4.58%
4.47%
4.27%
4.58%
3.66%
3.38%
3.06%
Employee Cost
-
292.71
281.39
286.39
264.49
235.31
196.59
176.40
149.35
127.87
90.09
% Of Sales
-
22.75%
24.43%
27.27%
23.09%
26.11%
21.65%
24.05%
18.93%
16.41%
12.57%
Manufacturing Exp.
-
122.29
95.70
110.32
120.03
89.12
79.19
61.23
59.96
52.55
45.35
% Of Sales
-
9.51%
8.31%
10.51%
10.48%
9.89%
8.72%
8.35%
7.60%
6.74%
6.33%
General & Admin Exp.
-
59.02
43.99
46.86
71.58
47.71
70.26
27.20
22.50
16.95
14.11
% Of Sales
-
4.59%
3.82%
4.46%
6.25%
5.29%
7.74%
3.71%
2.85%
2.18%
1.97%
Selling & Distn. Exp.
-
26.53
21.42
18.56
29.36
20.79
10.40
6.72
6.37
4.75
7.27
% Of Sales
-
2.06%
1.86%
1.77%
2.56%
2.31%
1.15%
0.92%
0.81%
0.61%
1.01%
Miscellaneous Exp.
-
30.52
26.96
26.89
27.22
25.51
20.48
17.23
14.68
17.32
7.27
% Of Sales
-
2.37%
2.34%
2.56%
2.38%
2.83%
2.26%
2.35%
1.86%
2.22%
1.61%
EBITDA
433.93
303.93
235.50
88.27
197.20
171.70
214.51
154.00
151.23
161.61
159.99
EBITDA Margin
28.21%
23.63%
20.45%
8.41%
17.21%
19.05%
23.63%
21.00%
19.17%
20.74%
22.33%
Other Income
10.61
36.27
17.16
31.41
20.90
40.09
22.23
15.56
32.62
29.34
11.36
Interest
58.79
75.53
91.80
58.65
41.17
21.87
4.56
3.68
2.66
3.13
3.93
Depreciation
119.72
112.99
107.87
95.50
79.80
53.98
43.78
42.06
37.22
30.64
23.14
PBT
278.18
151.68
52.99
-34.47
97.13
135.95
188.40
123.82
143.96
157.17
144.28
Tax
51.97
44.04
22.39
-7.36
41.68
48.85
33.49
26.18
33.91
42.04
35.62
Tax Rate
18.68%
35.63%
37.87%
21.35%
39.35%
24.82%
17.78%
18.22%
23.56%
27.54%
25.11%
PAT
226.21
78.30
31.88
-32.48
60.66
147.78
156.15
112.26
105.24
107.57
108.34
PAT before Minority Interest
226.21
78.30
31.96
-30.92
60.58
146.20
154.56
109.50
102.86
104.45
104.74
Minority Interest
0.00
0.00
-0.08
-1.56
0.08
1.58
1.59
2.76
2.38
3.12
3.60
PAT Margin
14.71%
6.09%
2.77%
-3.09%
5.30%
16.40%
17.20%
15.31%
13.34%
13.81%
15.12%
PAT Growth
184.33%
145.61%
-
-
-58.95%
-5.36%
39.10%
6.67%
-2.17%
-0.71%
 
EPS
11.56
4.00
1.63
-1.66
3.10
7.56
7.98
5.74
5.38
5.50
5.54

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,372.24
1,808.69
1,783.28
1,822.19
1,478.67
1,329.36
1,197.58
1,085.03
986.90
639.26
Share Capital
9.78
8.68
8.68
8.68
8.15
8.15
8.15
8.15
8.01
7.71
Total Reserves
2,362.46
1,800.01
1,774.60
1,813.51
1,470.51
1,321.21
1,189.43
1,076.88
978.88
631.55
Non-Current Liabilities
259.81
589.44
345.12
452.82
561.37
256.94
166.62
153.48
251.26
67.23
Secured Loans
231.96
560.16
242.92
353.49
473.87
164.48
80.39
67.09
141.20
0.03
Unsecured Loans
0.00
0.00
45.90
0.11
0.35
0.53
0.70
1.03
1.30
0.00
Long Term Provisions
25.54
22.43
17.65
19.08
15.48
26.17
21.77
20.32
16.89
13.96
Current Liabilities
674.23
693.59
784.45
611.54
587.46
410.82
253.44
265.84
236.90
222.07
Trade Payables
95.38
174.15
142.80
146.04
76.54
92.55
80.72
103.74
111.86
106.48
Other Current Liabilities
222.13
138.05
276.56
240.13
254.21
142.10
81.62
59.59
28.03
36.49
Short Term Borrowings
306.81
360.73
344.17
202.90
243.40
165.27
86.58
98.12
92.41
74.10
Short Term Provisions
49.91
20.66
20.92
22.46
13.31
10.89
4.52
4.39
4.60
5.00
Total Liabilities
3,297.74
3,082.98
2,903.93
2,875.50
2,616.33
1,989.21
1,610.02
1,499.13
1,472.22
930.89
Net Block
1,417.84
1,384.86
1,368.33
1,341.84
1,110.53
650.44
558.01
534.20
491.93
393.41
Gross Block
2,075.99
1,946.75
1,846.68
1,727.09
1,421.10
986.42
853.16
793.24
704.89
582.20
Accumulated Depreciation
658.15
561.89
478.35
385.25
310.57
335.98
295.15
259.04
212.96
188.79
Non Current Assets
2,312.07
2,206.74
2,134.37
1,988.30
1,729.60
1,365.35
1,064.96
827.16
742.33
576.68
Capital Work in Progress
821.77
718.78
655.33
506.18
541.29
666.25
429.12
209.85
140.51
91.90
Non Current Investment
34.54
39.91
42.66
34.23
21.22
10.45
2.25
20.79
27.99
34.15
Long Term Loans & Adv.
36.55
53.32
56.53
93.90
43.10
32.42
48.75
37.47
77.09
52.39
Other Non Current Assets
1.37
9.87
11.52
12.15
13.46
5.78
26.84
24.86
4.80
4.83
Current Assets
985.67
876.24
769.55
887.19
862.47
623.85
545.06
671.97
729.88
354.21
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
119.54
224.62
59.63
Inventories
347.93
344.93
319.82
355.24
333.19
226.43
187.67
188.71
190.00
134.23
Sundry Debtors
440.84
392.05
324.35
386.33
233.54
246.79
203.73
220.27
170.93
125.43
Cash & Bank
28.52
31.77
21.56
34.11
123.60
44.56
94.54
73.83
100.39
11.03
Other Current Assets
168.38
16.28
15.53
9.36
172.14
106.06
59.13
69.62
43.94
23.90
Short Term Loans & Adv.
150.79
91.22
88.29
102.16
146.24
95.97
47.99
56.59
31.61
21.18
Net Current Assets
311.44
182.65
-14.89
275.66
275.01
213.04
291.62
406.13
492.98
132.14
Total Assets
3,297.74
3,082.98
2,903.92
2,875.49
2,592.07
1,989.20
1,610.02
1,499.13
1,472.21
930.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
132.18
136.67
179.92
105.13
46.93
124.38
146.78
44.92
37.48
128.70
PBT
122.33
54.34
-38.28
102.26
196.79
188.40
143.70
136.77
146.49
140.36
Adjustment
195.04
221.44
147.81
109.34
4.03
41.32
20.44
18.83
17.19
20.61
Changes in Working Capital
-138.18
-97.92
102.77
-71.99
-106.29
-63.15
18.71
-69.66
-92.61
-2.70
Cash after chg. in Working capital
179.20
177.86
212.30
139.62
94.53
166.57
182.85
85.94
71.08
158.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-47.02
-41.19
-32.37
-34.48
-47.60
-42.20
-36.07
-41.02
-33.60
-29.56
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-199.08
-166.58
-232.61
-285.50
-404.28
-289.52
-196.16
-8.76
-262.23
-109.20
Net Fixed Assets
-78.45
-17.18
-22.18
384.16
-272.02
-4.28
-256.96
-136.75
-172.23
-92.14
Net Investments
-1,033.05
-2.53
-6.42
-18.18
-117.95
-4.44
133.96
95.51
-172.72
-14.09
Others
912.42
-146.87
-204.01
-651.48
-14.31
-280.80
-73.16
32.48
82.72
-2.97
Cash from Financing Activity
62.65
46.77
45.80
82.86
436.37
175.50
10.06
-60.91
312.70
-19.65
Net Cash Inflow / Outflow
-4.25
16.86
-6.89
-97.51
79.03
10.36
-39.32
-24.75
87.95
-0.15
Opening Cash & Equivalents
31.76
19.07
25.62
122.85
44.31
34.13
73.83
99.97
7.05
3.61
Closing Cash & Equivalent
28.52
31.76
19.07
25.34
123.34
44.31
34.36
73.83
99.97
6.43

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
121.29
104.19
205.44
209.93
181.37
163.06
146.89
133.09
123.17
82.91
ROA
2.45%
1.07%
-1.07%
2.20%
6.33%
8.61%
7.56%
7.41%
9.20%
11.58%
ROE
3.75%
1.78%
-1.71%
3.67%
10.41%
12.26%
10.30%
10.62%
13.60%
17.92%
ROCE
6.94%
5.49%
0.80%
5.94%
10.73%
12.41%
11.05%
11.71%
15.91%
19.90%
Fixed Asset Turnover
0.64
0.61
0.59
0.73
0.75
0.99
0.89
1.06
1.22
1.36
Receivable days
118.16
113.53
123.51
98.75
94.03
90.56
105.51
90.20
69.00
52.26
Inventory Days
98.29
105.35
117.32
109.68
110.03
83.24
93.66
87.32
75.49
66.97
Payable days
123.69
146.72
126.70
106.00
107.72
47.69
58.00
61.51
60.89
60.10
Cash Conversion Cycle
92.76
72.15
114.12
102.43
96.33
126.11
141.17
116.00
83.61
59.13
Total Debt/Equity
0.25
0.52
0.45
0.37
0.57
0.29
0.16
0.18
0.24
0.14
Interest Cover
2.62
1.59
0.35
3.48
9.92
42.34
40.09
55.10
49.69
37.07

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility
    24th Jun 2026, 09:58 AM

    This commissioning marks a significant evolution of Shilpa Medicare’s over 25 years of deep-rooted expertise in highly potent compound manufacturing

    Read More
  • Shilpa Medicare’s arm enters into strategic equity partnership with Gate2Brain
    3rd Jun 2026, 12:00 PM

    G2B-002 delivers SN-38, a potent anticancer agent, across the blood-brain barrier via Gate2Brain's proprietary MiniAp4 peptide shuttle

    Read More
  • Shilpa Medicare - Quarterly Results
    23rd May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.